Učitavanje...
Bevacizumab or laser for aggressive posterior retinopathy of prematurity
PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...
Spremljeno u:
| Izdano u: | Taiwan J Ophthalmol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications & Media Pvt Ltd
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6302568/ https://ncbi.nlm.nih.gov/pubmed/30637196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_69_18 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|